Position in RPRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$60,334,852
+$10,052,603 QoQ
Shares Held
1,076,063
+2.7% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#55
of 646 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL SARL holds $261,404,130 across 8 Biotechnology names. RPRX ranks #2 (23.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,718 | $104,669,952 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
1,076,063 | $60,334,852 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
175,542 | $50,024,203 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
58,080 | $17,483,822 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,458 | $15,874,081 | |
| 6 | ASND |
Ascendis Pharma A/S
|
26,222 | $6,993,931 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
101,238 | $5,521,520 | |
| 8 | CYTK |
Cytokinetics Inc
|
5,890 | $501,769 |
All Filings in RPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,334,852 | 1,076,063 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $50,282,249 | 1,048,202 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $20,668,381 | 534,896 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $13,002,867 | 368,562 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,698,328 | 324,683 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||